This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Sep;14(10):911-2.

doi: 10.1016/S1470-2045(13)70382-6. Epub 2013 Aug 13.

BEACOPPescalated versus ABVD in advanced Hodgkin's lymphoma

Marc André¹, André Bosly

Affiliations

PMID: 23948347
DOI: 10.1016/S1470-2045(13)70382-6

Comment

BEACOPPescalated versus ABVD in advanced Hodgkin's lymphoma

Marc André et al. Lancet Oncol. 2013 Sep.

. 2013 Sep;14(10):911-2.

doi: 10.1016/S1470-2045(13)70382-6. Epub 2013 Aug 13.

Authors

Marc André¹, André Bosly

Affiliation

¹ CHU UCL Mont-Godinne-Dinant, Yvoir, Belgium. andre.bosly@uclouvain.be

PMID: 23948347
DOI: 10.1016/S1470-2045(13)70382-6

No abstract available

PubMed Disclaimer

Comment on

Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis.
Skoetz N, Trelle S, Rancea M, Haverkamp H, Diehl V, Engert A, Borchmann P. Skoetz N, et al. Lancet Oncol. 2013 Sep;14(10):943-52. doi: 10.1016/S1470-2045(13)70341-3. Epub 2013 Aug 13. Lancet Oncol. 2013. PMID: 23948348

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information